Skip to main content

Table 2 Pooled estimates of autoantibodies

From: Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis

Autoantibody

Sensitivity (95% CI)

Specificity (95% CI)

Diagnostic odds ratio (95% CI)

P53

0.184 (0.093–0.332)

0.962 (0.912–0.984)

5.760 (4.029–8.220)

MUC1

0.498 (0.209–0.789)

0.691 (0.257–0.935)

2.215 (0.440–11.143)

HER2

0.453 (0.064–0.910)

0.794 (0.294–0.973)

3.200 (1.700–6.025)

HSP60

0.558 (0.210–0.857)

0.802 (0.316–0.973)

5.122 (2.145–12.229)

P16

0.216 (0.142–0.314)

0.941 (0.878–0.972)

4.373 (2.329–8.209)

Cyclin B1

0.149 (0.105–0.207)

0.977 (0.946–0.990)

7.455 (2.816–19.733)

c-Myc

0.103 (0.060–0.172)

0.966 (0.919–0.986)

3.230 (1.071–9.740)